Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ovarian Tissue Cryopreservation in the Setting of Gender-affirming Therapy

NCT05863676 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT05863676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05863676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ovarian Tissue Cryopreservation in the Setting of Gender-affirming Therapy
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Active, not recruiting
Start date
July 14, 2020
Completion date
July 31, 2030
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gender dysphoria, transgender